Zhang, Y., Sun, L., Ren, S., Pan, F., Zhu, H., Dang, Q., Tian, P., Liu, F., Wu, L., Guo, S., Su, Y., Zhang, J., Wang, Y., Chen, K., Meng, R., Cheng, Y., Hu, Y., Jia, Y., Li, M., Xu, R. (2025). Phase 1 study of SHR-1826, a c-MET–directed antibody-drug-conjugate (ADC), in advanced solid tumors.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.106